vs
Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and zSpace, Inc. (ZSPC). Click either name above to swap in a different company.
BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $4.8M, roughly 1.7× zSpace, Inc.).
BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.
zSpace, Inc. is an American technology firm based in San Jose, California that delivers virtual and augmented reality experiences in STEM, CTE, and career readiness programs from a computer. zSpace mostly provides AR/VR technology to the education market, allowing teachers and learners to interact with simulated objects in virtual environments.
BHST vs ZSPC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.4M | $4.8M |
| Net Profit | — | $-7.3M |
| Gross Margin | 60.3% | 49.1% |
| Operating Margin | — | -116.2% |
| Net Margin | — | -150.3% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.8M | ||
| Q3 25 | $8.4M | $8.8M | ||
| Q2 25 | $8.1M | $7.5M | ||
| Q1 25 | $7.7M | $6.8M | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $6.0M | — |
| Q4 25 | — | $-7.3M | ||
| Q3 25 | — | $-6.2M | ||
| Q2 25 | — | $-6.1M | ||
| Q1 25 | — | $-5.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | 49.1% | ||
| Q3 25 | 60.3% | 51.2% | ||
| Q2 25 | 60.0% | 42.6% | ||
| Q1 25 | 58.2% | 47.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | -116.2% | ||
| Q3 25 | — | -54.5% | ||
| Q2 25 | — | -84.9% | ||
| Q1 25 | — | -79.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | -150.3% | ||
| Q3 25 | — | -70.2% | ||
| Q2 25 | — | -81.8% | ||
| Q1 25 | — | -86.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.26 | ||
| Q2 25 | — | $-0.27 | ||
| Q1 25 | — | $-0.26 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $17.7M |
| Stockholders' EquityBook value | — | $-22.5M |
| Total Assets | — | $7.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $17.7M | ||
| Q3 25 | — | $18.7M | ||
| Q2 25 | — | $18.1M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | $-22.5M | ||
| Q3 25 | — | $-19.7M | ||
| Q2 25 | — | $-22.3M | ||
| Q1 25 | — | $-19.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $13.5M | ||
| Q2 25 | — | $12.1M | ||
| Q1 25 | — | $9.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-3.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-3.9M | ||
| Q3 25 | — | $-2.5M | ||
| Q2 25 | — | $-6.9M | ||
| Q1 25 | — | $-4.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHST
Segment breakdown not available.
ZSPC
| Transferred At Point In Time | $4.6M | 94% |
| Other | $287.0K | 6% |
